News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,443 Results
Type
Article (186)
Press Release (1257)
Section
Business (330)
Career Advice (1)
Deals (59)
Drug Delivery (3)
Drug Development (111)
FDA (69)
Job Trends (29)
News (576)
Policy (74)
Tag
Academia (4)
Alliances (147)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (3)
Approvals (69)
Artificial intelligence (2)
Best Places to Work (20)
Biosimilars (36)
Cancer (5)
Cardiovascular disease (2)
Career advice (1)
Clinical research (92)
Collaboration (6)
COVID-19 (5)
C-suite (2)
Data (4)
Diagnostics (21)
Digital health (1)
Drug discovery (2)
Drug pricing (8)
Earnings (80)
Events (130)
Executive appointments (3)
FDA (71)
Funding (3)
GLP-1 (3)
Government (14)
Healthcare (48)
Immunology and inflammation (2)
Infectious disease (6)
Inflammatory bowel disease (1)
Inflation Reduction Act (1)
Intellectual property (1)
IPO (31)
IRA (2)
Job creations (9)
Job search strategy (1)
Layoffs (3)
Legal (18)
Lung cancer (1)
Manufacturing (9)
Medical device (43)
Medtech (43)
Mergers & acquisitions (28)
Metabolic disorders (1)
Multiple sclerosis (1)
Neuroscience (4)
NextGen: Class of 2025 (10)
Non-profit (2)
Northern California (4)
Obesity (1)
Opinion (2)
Patents (2)
People (69)
Pharmacy benefit managers (2)
Phase I (30)
Phase II (37)
Phase III (41)
Pipeline (1)
Podcasts (1)
Policy (3)
Postmarket research (4)
Preclinical (5)
Prostate cancer (1)
Radiopharmaceuticals (1)
Real estate (13)
Regulatory (49)
Research institute (4)
Series B (1)
Southern California (4)
Startups (8)
Supply chain (1)
The Weekly (1)
United States (22)
Vaccines (1)
Weight loss (1)
Date
Last 7 days (2)
Last 30 days (10)
Last 365 days (110)
2025 (20)
2024 (117)
2023 (92)
2022 (212)
2021 (166)
2020 (161)
2019 (109)
2018 (112)
2017 (80)
2016 (87)
2015 (89)
2014 (42)
2013 (30)
2012 (30)
2011 (20)
2010 (14)
Location
Asia (378)
Australia (6)
California (9)
Canada (2)
China (1)
Europe (148)
Illinois (2)
Japan (2)
Maryland (1)
Massachusetts (2)
Missouri (2)
New Jersey (1)
New York (1)
Northern California (4)
Southern California (4)
Texas (2)
Washington D.C. (1)
1,443 Results for "samsung neurologica".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Legal
J&J Takes Samsung Bioepis to Court Over ‘Unlawful’ Stelara Biosimilar Sublicense
Samsung Bioepis allegedly entered into an agreement with a third-party health company, allowing it to market its own private label of a Stelara biosimilar.
February 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Samsung Invests in C2N Diagnostics
March 13, 2025
·
4 min read
Press Releases
Samsung Bioepis Announces US Launch of PYZCHIVA® (ustekinumab-ttwe), Biosimilar to Stelara
February 24, 2025
·
8 min read
Press Releases
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
February 17, 2025
·
4 min read
Press Releases
FDA Approves Samsung Bioepis’ OSPOMYV™, XBRYK™ (denosumab-dssb), a Biosimilar to Prolia and Xgeva
February 17, 2025
·
9 min read
Press Releases
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
January 8, 2025
·
3 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
January 22, 2025
·
4 min read
Press Releases
Samsung Bioepis Releases First Quarter 2025 US Biosimilar Market Report
January 16, 2025
·
1 min read
Manufacturing
Samsung Biologics Continues Mega-Deal Streak With $1.4B European Contract
The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few months later.
January 23, 2025
·
2 min read
·
Tristan Manalac
Genetown
NeuroLogica Corp Receives Innovative Technology Designation from Vizient for OmniTom Elite PCD
NeuroLogica Corp. announces its OmniTom Elite PCD has received an Innovative Technology designation from Vizient, Inc., the largest provider-driven healthcare performance improvement company in the country.
January 11, 2024
·
3 min read
1 of 145
Next
